Therefore, the present study aimed to identify whether a single dose of acarbose had the potential to affect incretin levels beyond its glycemic effect in drug-naive Chinese patients newly diagnosed with T2DM. The gene discussed is GCG; the disease is type 2 diabetes mellitus.